Prophylaxis with gentamicin reduces bacterial infection-related morbidity and mortality caused by permanent tunneled central venous catheter;La profilaxis con gentamicina disminuye la morbi-mortalidad infecciosa bacteriana causada por el catéter venoso central permanente tunelizado

Nefrologia

Volumn 27, Issue 2, 2007, Pages 228-229

  Fernández Gallego Ballenilla, Juan ^a   Alonso, A ^a   Sujan, S ^a   Gutierrez E ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN;

ADULT; AGED; BACTERIAL INFECTION; CENTRAL VENOUS CATHETERIZATION; EQUIPMENT DESIGN; FEMALE; HUMAN; INDWELLING CATHETER; INSTRUMENTATION; LETTER; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT DESIGN; FEMALE; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 34548446759     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in US hemodialysis patients. Kidney Int 60: 1443-1451, 2001.
2. Pastan S, Michael Sousie J, McClellan WM: Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62: 620-626, 2002.
3. Fernández-Gallego J, López V, Martín MA, Toledo R: El catéter venoso central crónico tunelizado aumenta la mortalidad en hemodiálisis. Nefrología 25: 720-721, 2005.
4. Nassar GM, Ayus JC: Infectious complications of the hemodialysis access. Kidney Int 60: 1-13, 2001.
5. Ishani A, Collins AJ, Herzog ChA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 Study. Kidney Int 68: 311-318, 2005.
6. Hernández-Jaras J, García-Pérez E, Torregrosa E, Pons R, Calvo C, Serra M, Orts M, Rius A, Camacho G, Bernat A, Sánchez-Canel JJ: Seguimiento a largo plazo de catéteres permanentes en pacientes con dificultad en la obtención de un acceso vascular definitivo. Nefrología 24: 446-452, 2004.
7. McIntyre CW, Hulme LJ, Taal M, Fluch RJ: Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66: 801-805, 2004.
8. Saxena AK, Panhotra BR: Locking hemodialysis catheters with cefotaxime instead of gentamicin to avoid potential ototoxicity. Kidney Int 67: 2505-2506, 2005.
9. Jaber BL: Nephrology Forum: bacterial infections in hemodialysis patients: pathogenesis and prevention. Kidney Int 67: 2508-2519, 2005.
10. Saxena AK, Panthotra BR, Sundaram DS, Al-Hafiz A, Naguib M, Venkateshappa CK, Abu-Oum BA, Hussain SMN, Al Ghandi AMA-A: Tunneled catheters outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 70: 1629-1636, 2006.
11. NKF K/DOQI Guidelines: Clinical practice guidelines for vascular access: Guidelines 7: prevention and treatment of catheter and port complications. Am J Kidney Dis 48 Supl. 1 (S 176-S 247), 2006.